Vascular Peptide Bioregulator

Vesugen

Lys-Glu-Asp • KED Tripeptide

Vesugen is a synthetic three-amino-acid peptide studied in vascular, endothelial, smooth-muscle, and aging models. Its tissue-specific research is more coherent than that of many bioregulators, but modern independent clinical validation and standardized injectable dosing are still missing.

Vascular Research Endothelial Signaling Gene Regulation Vascular Aging

Protocol Snapshot

Quick reference before the deep dive

Verified Vendors

Vesugen

Compare Verified Vendors

Current price and availability
Price per mg and vial-size comparison
Testing and fulfillment details

Compare

View Price Index

Daily Dose

500mcg–2mg

Community research convention; no validated human dose.

Cycle

10–30 Days

Short daily courses are most commonly discussed.

Route

Subcutaneous injection

Commonly discussed injectable research route.

Suggested Timing

Consistent Daily

No evidence establishes a superior time of day.

Peptide Grade

GradeB

Vesugen has KED-specific vascular and endothelial research plus recurring positive circulation reports from the community, but independent modern trials, validated injectable dosing, and long-term cardiovascular safety data remain limited.

Research Community Safety

Foundation

Research context, mechanisms, and practical use cases

What Is Vesugen?

Vesugen is the synthetic tripeptide Lys-Glu-Asp, also written KED. It was developed from the peptide-bioregulator research tradition that studies short tissue-associated amino-acid sequences as potential regulators of gene expression and cellular function.

Vesugen is positioned as a vascular bioregulator. Published work has examined KED in cultured vascular cells, aging-related endothelial and smooth-muscle models, gene-expression systems, and animal experiments involving vascular and neural tissues.

The evidence supports a biologically active research signal, not a proven treatment for atherosclerosis, circulation problems, hypertension, or clotting disorders. Most findings are preclinical, many come from closely related research groups, and direct modern clinical outcomes are limited.

Vesugen Benefits

Potential benefits are best understood as vascular research targets rather than established medical effects.

Endothelial Function

Cell studies have examined age-related proliferation and signaling in vessel-lining cells.

Vascular Remodeling

KED has been studied in vascular smooth-muscle and restenosis-related research contexts.

Gene Regulation

Short-peptide research proposes sequence-specific DNA interactions and changes in protein expression.

Vascular Aging

Aging-related endothelial decline is the central use case, although clinical benefit remains unconfirmed.

Protocol Planning

Dosing, cycling, and preparation

Vesugen Dosing Protocol

No modern human dose-finding trial has established an optimal injectable dose, frequency, or cycle. The ranges below reflect community research conventions, not an approved protocol.

Standard Protocol

Dose

500mcg–2mg once daily

Route

Subcutaneous injection

Cycle

10–30 days

Timing

Any consistent time

Practical Progression

Low

500mcg daily

Moderate

1mg daily

Upper Convention

2mg daily

Priority

Track blood pressure and vascular symptoms rather than relying on “circulation” impressions

Vesugen Reconstitution

20mg Vial

Diluent

3ml bacteriostatic water

Concentration

6.67mg/mL

Per U-100 Unit

66.7mcg

Storage

Refrigerate after reconstitution

Reconstitution Calculator

Dose Conversion

500mcg

7.5 units

1mg

15 units

1.5mg

22.5 units

2mg

30 units

Anecdotal Data Points

Community-reported outcomes and recurring patterns

Self-reported anecdotal experiences aggregated from public and private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

Enthusiasts repeatedly describe warmer extremities, better blood flow, reduced leg heaviness, and steadier exercise tolerance.
Some of the strongest reports involve visible or symptomatic improvement in varicose veins, swelling, and chronic venous discomfort.
Users often describe Vesugen as one of the more noticeable Khavinson bioregulators because the target—circulation and vascular comfort—is easier to observe.
Positive reports exist with oral and injectable products, and satisfied users commonly repeat short courses rather than taking it continuously.

Negative Reports

Some users notice little during a short cycle, particularly without a defined vascular symptom or measurable endpoint.
Dramatic claims about varicose veins or circulation are individual reports, not controlled evidence, and may involve oral products or concurrent interventions.
Occasional reports include headache, flushing, dizziness, or injection-site irritation; these are not well quantified.

Stacking & Synergy

Potential Vesugen pairings and tracking context

Vesugen + GHK-Cu

Tissue-remodeling pairing. GHK-Cu has broader wound and extracellular-matrix research; Vesugen adds a vascular-cell hypothesis. Combination benefit is untested.

Vesugen + Pinealon

Vascular-brain pairing. Vesugen covers endothelial support while Pinealon targets neural resilience. Community protocols cite focus, memory, reaction time, HRV, and vascular-component brain fog, but controlled synergy data are absent.

Vesugen + Cardiogen

Heart-and-vessel pairing. Vesugen targets vascular endothelium while Cardiogen is positioned around heart-muscle cells. Commonly discussed for endurance and cardiovascular longevity, without controlled combination data.

Vesugen + Epitalon

Healthy-aging pairing. This combines vascular and circadian-longevity bioregulator concepts, but overlapping subtle outcomes make clean attribution difficult.

Free with login

Track in Journal

Vesugen needs objective cardiovascular context; vague “better circulation” is not enough to judge a subtle compound.

Dose, timing, and cycle day.
Heart rate, blood pressure, palpitations, and swelling.
Walking tolerance, training capacity, and recovery.
Cardiovascular medications, stimulants, and other compounds.

Start Tracking

Safety Notes

Side effects, contraindications, and precautions

Vesugen Side Effects

Compound-specific human safety data are sparse. Cardiovascular symptoms should never be dismissed as an expected “adjustment” to an experimental peptide.

Published Research

Published work focuses mainly on cellular mechanisms and animal models.
No modern long-term injectable safety program or formal cardiovascular interaction study is available.

What Users Report

Most reports describe no obvious acute effect.
Headache, flushing, dizziness, and injection-site irritation are occasionally reported.

Vesugen Contraindications and Precautions

Do Not Use If You Have

Known hypersensitivity to Vesugen or its components.
Pregnancy or breastfeeding, because safety data are unavailable.

Use Caution With

Known cardiovascular disease, uncontrolled blood pressure, clotting disorders, or unexplained vascular symptoms.
Anticoagulants, antiplatelet drugs, antihypertensives, vasodilators, or stimulant use.

Drug Interactions

No formal interaction studies have been conducted. Combining an experimental vascular peptide with cardiovascular medications creates unknown pharmacologic and monitoring risks.

Regulatory Status

Vesugen is not FDA approved for any medical indication. It has no established human therapeutic dose or approved injectable route.

FINAL VERDICT

Peptide Protocol's Opinionated Opinion

This is not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

Vesugen is one of the smarter, less-hyped bioregulators out there—and the peptide community is right to like it.

It hits endothelial gene expression in a foundational way that beats generic NO boosters. Community feedback on veins popping, better recovery, HRV gains, and smoother cardio output is solid, especially short-cycled with Pinealon (brain flow) or Cardiogen (heart/vessel synergy).

Our take: Worth adding to a dialed protocol. Not a miracle, but low-risk/high-upside for circulation and performance when done right. We primarily used it as a pre-workout.